Classification of Hematolymphoid Tumors

WHO 2022 & ICC 2022 Hematolymphoid Diagnostic Criteria — 210 WHO + 181 ICC Entities

Classification of Hematolymphoid Tumors is a reference tool for pathologists, hematopathologists, and clinicians. It displays WHO 2022 and ICC 2022 diagnostic criteria for all major hematolymphoid neoplasms directly in the Chrome side panel, keeping criteria accessible without leaving your active tab. WHAT IT INCLUDES: - 210 WHO 2022 entities — organized across Myeloid, B-cell, T/NK-cell, Histiocytic, and Stromal categories - 181 ICC 2022 entities — with full parallel coverage - 3-level hierarchy: Classification → Subcategory → Entity - Diagnostic criteria, immunophenotype, cytogenetics, and morphologic features for each entity - Built-in search across all entities - Entities with interactive diagnostic calculators marked with a green indicator FEATURES: - Side panel integration — stays open alongside any webpage - Light/dark mode (universal across WHO and ICC) - Font size adjustment (small / medium / large) - Fully offline — no internet connection required - No sign-in, no data collection, no tracking - Built-in feedback form for reporting errors or suggestions Designed for daily clinical and academic use in hematopathology. Based on: Alaggio et al. Leukemia 2022 (WHO 5th ed.) and Arber et al. Blood 2022 (ICC 2022).